scispace - formally typeset
I

Indrani Sarkar

Researcher at Narula Institute of Technology

Publications -  6
Citations -  18

Indrani Sarkar is an academic researcher from Narula Institute of Technology. The author has contributed to research in topics: Quantitative structure–activity relationship & Molecular descriptor. The author has an hindex of 3, co-authored 6 publications receiving 17 citations.

Papers
More filters
Book ChapterDOI

Quantitative Structure–Activity Relationship (QSAR) Study of Some DNA-Intercalating Anticancer Drugs

TL;DR: To explore whether molecular descriptors can explain their DNA-binding affinity and toxicity, 23 antitumor molecules, which are being used clinically as drugs, are analyzed by rigorous statistical calculations.
Journal ArticleDOI

Comparative analysis of binding sites of human meprins with hydroxamic acid derivative by molecular dynamics simulation study

TL;DR: To compare the molecular events underlying ligand affinity, homology modeling of the protease domain of humep-α and -β based on the astacin crystal structure followed by energy minimization and molecular dynamics simulation of fully solvated proteases with inhibitor Pro-Leu-Gly-hydroxamate in S subsites were performed.
Book ChapterDOI

Computational Methodologies Followed in Structure Based In-Silico Drug Design: An Example

TL;DR: An attempt through molecular modeling and simulation methods is presented here to explain binding affinities of different derivatives of drugs and also the role of some important amino acid residues in the active site of the InhA.
Journal ArticleDOI

Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.

TL;DR: Comparison of the interaction energies for each system helped to conclude that the hydroxamic acid-based inhibitors are the most potent inhibitors of meprin-α and-β.
Book ChapterDOI

To Explore Compounds as Tuberculosis Inhibitors—A Combination of Pharmacophore Modelling, Virtual Screening and Molecular Docking Studies

TL;DR: A ligand-based 3D pharmacophore and QSAR approach is used for the selection of potentially active compounds for inhibitory action against the enoyl-ACP-reductase from Mycobacterium tuberculosis, followed by molecular modelling, dynamic simulation and binding energy calculation methods.